The present invention relates to UPR pathway inhibitors, in particular PERK and IRE-1A inhibitors for use in the prevention or treatment of neurodevelopmental disorders, such as microcephaly caused by ZIKV.
PERK AND IRE-1A INHIBITORS AGAINST NEURODEVELOPMENTAL DISORDERS